Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: long-term results of the randomized controlled phase II PARC trial - Liermann, Jakob; Munter, Marc; Naumann, Patrick; Abdollahi, Amir; Krempien, Robert; Debus, Jürgen (Clinical and translational radiation oncology, 2022)
Gesehen am 18.05.2022